Lexeo Therapeutics (LXEO) Interest & Investment Income (2022 - 2026)

Lexeo Therapeutics (LXEO) has 5 years of Interest & Investment Income data on file, last reported at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income rose 17708.33% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (up 19.63% YoY), and the FY2025 full-year result was $6.1 million, down 18.87% from the prior year.
• Interest & Investment Income fell to $2.1 million in Q1 2026, from $2.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $2.3 million in Q2 2024 to a low of -$12000.0 in Q1 2025.
• A 5-year average of $1.2 million and a median of $1.3 million in 2025 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income sank 100.73% in 2025 and surged 17708.33% in 2026, its largest moves.
• Tracing LXEO's Interest & Investment Income over 5 years: stood at $676000.0 in 2022, then jumped by 63.02% to $1.1 million in 2023, then surged by 32.94% to $1.5 million in 2024, then surged by 51.06% to $2.2 million in 2025, then slipped by 4.52% to $2.1 million in 2026.
• Business Quant data shows LXEO's Interest & Investment Income at $2.1 million in Q1 2026, $2.2 million in Q4 2025, and $1.5 million in Q3 2025.